Anka G Ehrhardt
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Genetic Neurodegenerative Diseases, Single-cell and spatial transcriptomics, Neuroscience and Neuropharmacology Research, DNA Repair Mechanisms
Most-Cited Works
- → CAG Repeat Not Polyglutamine Length Determines Timing of Huntington’s Disease Onset(2019)541 cited
- → A genetically encoded fluorescent sensor of ERK activity(2008)352 cited
- → JNK2 Is a Positive Regulator of the cJun Transcription Factor(2006)158 cited
- → A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake(2010)107 cited
- → Supervillin modulation of focal adhesions involving TRIP6/ZRP-1(2006)63 cited
- → Requirement of JIP scaffold proteins for NMDA-mediated signal transduction(2007)40 cited
- → Spindle pole fragmentation due to proteasome inhibition(2005)36 cited
- → A large‐conductance K+ channel that is inhibited by the cytoskeleton in the smooth muscle cell line DDT1 MF‐2.(1996)26 cited
- → High-Throughput Analysis of Clinical Flow Cytometry Data by Automated Gating(2019)25 cited
- → Inhibition of cholesteryl ester transfer protein by anacetrapib does not impair the anti-inflammatory properties of high density lipoprotein(2012)20 cited